相关实验视频

Updated: Jun 26, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

针对多发性骨髓瘤的CAR T细胞疗法的毒性

Aimaz Afrough¹, Pearl Rajan Abraham², Laura Turer²

¹Myeloma, Waldenstrom's, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA.

Acta haematologica

|May 8, 2024

概括

针对BCMA的新仿真抗原受体 (CAR) -T细胞疗法为复发性和耐火性多发性骨髓瘤 (RRMM) 提供了希望. 管理像细胞因子释放综合征 (CRS) 这样的毒性是改善患者安全和治疗结果的关键.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
细胞疗法细胞疗法

背景情况:

伊德卡巴泰基因维克卢塞尔 (ide-cel) 和基尔塔卡巴泰基因自动基因 (cilta-cel) 是FDA批准的化学抗原受体 (CAR) -T细胞疗法.
这些疗法向B细胞成熟抗原 (BCMA),用于治疗复发性和耐火性多发性骨髓瘤 (RRMM).

研究的目的:

探索与CAR-T细胞疗法相关的毒性管理策略.
为了提高CAR-T细胞疗法的安全性,以获得更广泛的临床应用.

主要方法:

研究CAR-T细胞疗法相关毒性背后的机制.
开发量身定制的干预措施和完善临床方案.
确定用于风险分层和监测的生物标志物.

主要成果:

卡尔-T细胞疗法在RRMM中显示出显著的疗效.
常见的毒性包括细胞因子释放综合征 (CRS),免疫效应细胞相关的神经毒性综合征 (ICANS),细胞衰竭,感染和低球蛋白血症.

结论:

有效的毒性管理对于优化CAR-T细胞治疗至关重要.
通过协议改进,生物标志物识别和监测,不断进步是必不可少的.
加强安全措施将促进CAR-T疗法的更广泛的门诊使用.

关键词:

在CAR-T疗法中,多发性骨髓瘤是一种多发性骨髓瘤.有毒性有毒性

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...